Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563758465> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2563758465 endingPage "128" @default.
- W2563758465 startingPage "125" @default.
- W2563758465 abstract "The immune checkpoint targeted agents, anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and anti-programed cell death 1 (PD-1) or anti-programmed death ligand 1 (PD-L1) inhibitors are frequently associated with cutaneous side effects that are often dose limiting and can lead to discontinuation of therapy. Ipilimumab, a CTLA-4 inhibitor, is most commonly associated with a morbilliform eruption on the trunk and extremities and pruritus. More severe cutaneous toxicities reported include toxic epidermal necrolysis and severe drug rash with eosinophila and systemic symptoms. Recent case reports of Sweet syndrome and cutaneous sarcoidosis have also recently been described after treatment with ipilimumab. The cutaneous events usually occur early in the course of treatment and are dose dependent. PD-1 inhibitors, nivolumab and pembrolizumab, induce similar but less severe toxicities compared with the CTLA-4 inhibitors. The most common cutaneous adverse events include lichenoid reactions, eczema, vitiligo, and pruritus. Lichenoid oral mucosal lesions located on the tongue, buccal mucosa, lips, or gingivae or located on all of these have also recently been described. The time of onset of the cutaneous events with the PD-1 inhibitors occurs later than that seen with the CTLA-4 inhibitors. Anti-PD-L1 antibodies, such as atezolizumab, have a similar side effect profile compared with the PD-1 inhibitors. Combination of immune checkpoint inhibitors, ipilimumab and nivolumab, has recently been approved for the treatment of advanced melanoma. The combination therapy is associated with a more severe side effect profile compared with the agents used as monotherapy. We discuss the most frequently encountered cutaneous side effects of the immune checkpoint inhibitors and review the recommended management strategies." @default.
- W2563758465 created "2017-01-06" @default.
- W2563758465 creator A5000011359 @default.
- W2563758465 creator A5012428217 @default.
- W2563758465 creator A5048000762 @default.
- W2563758465 creator A5079847536 @default.
- W2563758465 date "2017-03-01" @default.
- W2563758465 modified "2023-10-11" @default.
- W2563758465 title "Cutaneous adverse effects of the immune checkpoint inhibitors" @default.
- W2563758465 cites W1923122596 @default.
- W2563758465 cites W1977582499 @default.
- W2563758465 cites W1991301773 @default.
- W2563758465 cites W2002673340 @default.
- W2563758465 cites W2051093099 @default.
- W2563758465 cites W2051493280 @default.
- W2563758465 cites W2074895307 @default.
- W2563758465 cites W2080013502 @default.
- W2563758465 cites W2080759679 @default.
- W2563758465 cites W2101653483 @default.
- W2563758465 cites W2123544669 @default.
- W2563758465 cites W2128758225 @default.
- W2563758465 cites W2137349687 @default.
- W2563758465 cites W2149748445 @default.
- W2563758465 cites W2160834915 @default.
- W2563758465 cites W2233818050 @default.
- W2563758465 cites W2234757355 @default.
- W2563758465 cites W2324653442 @default.
- W2563758465 cites W2376844206 @default.
- W2563758465 cites W2464708391 @default.
- W2563758465 cites W2487827606 @default.
- W2563758465 cites W4256189622 @default.
- W2563758465 doi "https://doi.org/10.1016/j.currproblcancer.2016.12.001" @default.
- W2563758465 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28190531" @default.
- W2563758465 hasPublicationYear "2017" @default.
- W2563758465 type Work @default.
- W2563758465 sameAs 2563758465 @default.
- W2563758465 citedByCount "147" @default.
- W2563758465 countsByYear W25637584652017 @default.
- W2563758465 countsByYear W25637584652018 @default.
- W2563758465 countsByYear W25637584652019 @default.
- W2563758465 countsByYear W25637584652020 @default.
- W2563758465 countsByYear W25637584652021 @default.
- W2563758465 countsByYear W25637584652022 @default.
- W2563758465 countsByYear W25637584652023 @default.
- W2563758465 crossrefType "journal-article" @default.
- W2563758465 hasAuthorship W2563758465A5000011359 @default.
- W2563758465 hasAuthorship W2563758465A5012428217 @default.
- W2563758465 hasAuthorship W2563758465A5048000762 @default.
- W2563758465 hasAuthorship W2563758465A5079847536 @default.
- W2563758465 hasConcept C126322002 @default.
- W2563758465 hasConcept C143998085 @default.
- W2563758465 hasConcept C16005928 @default.
- W2563758465 hasConcept C197934379 @default.
- W2563758465 hasConcept C203014093 @default.
- W2563758465 hasConcept C2777701055 @default.
- W2563758465 hasConcept C2780030458 @default.
- W2563758465 hasConcept C2780057760 @default.
- W2563758465 hasConcept C2781433595 @default.
- W2563758465 hasConcept C71924100 @default.
- W2563758465 hasConcept C8891405 @default.
- W2563758465 hasConceptScore W2563758465C126322002 @default.
- W2563758465 hasConceptScore W2563758465C143998085 @default.
- W2563758465 hasConceptScore W2563758465C16005928 @default.
- W2563758465 hasConceptScore W2563758465C197934379 @default.
- W2563758465 hasConceptScore W2563758465C203014093 @default.
- W2563758465 hasConceptScore W2563758465C2777701055 @default.
- W2563758465 hasConceptScore W2563758465C2780030458 @default.
- W2563758465 hasConceptScore W2563758465C2780057760 @default.
- W2563758465 hasConceptScore W2563758465C2781433595 @default.
- W2563758465 hasConceptScore W2563758465C71924100 @default.
- W2563758465 hasConceptScore W2563758465C8891405 @default.
- W2563758465 hasIssue "2" @default.
- W2563758465 hasLocation W25637584651 @default.
- W2563758465 hasLocation W25637584652 @default.
- W2563758465 hasOpenAccess W2563758465 @default.
- W2563758465 hasPrimaryLocation W25637584651 @default.
- W2563758465 hasRelatedWork W2062691140 @default.
- W2563758465 hasRelatedWork W2155654588 @default.
- W2563758465 hasRelatedWork W2287821501 @default.
- W2563758465 hasRelatedWork W2466451466 @default.
- W2563758465 hasRelatedWork W2475687906 @default.
- W2563758465 hasRelatedWork W2580215808 @default.
- W2563758465 hasRelatedWork W2901619788 @default.
- W2563758465 hasRelatedWork W2981928411 @default.
- W2563758465 hasRelatedWork W3016822790 @default.
- W2563758465 hasRelatedWork W3185931698 @default.
- W2563758465 hasVolume "41" @default.
- W2563758465 isParatext "false" @default.
- W2563758465 isRetracted "false" @default.
- W2563758465 magId "2563758465" @default.
- W2563758465 workType "article" @default.